NCT05475301View on ClinicalTrials.gov

Incidence, Risk Factor, Treatment and Overall Survival of Locally Recurrent Rectal Cancer

CompletedOBSERVATIONAL
Enrollment

1,431

Participants

Timeline

Start Date

January 1, 2015

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Rectal NeoplasmsNeoplasm Recurrence, Local
All Listed Sponsors
lead

Radboud University Medical Center

OTHER

NCT05475301 - Incidence, Risk Factor, Treatment and Overall Survival of Locally Recurrent Rectal Cancer | Biotech Hunter | Biotech Hunter